MCW Cancer Center Associate Director of Prevention and Control
Melinda Stolley, PhD
Dr. Stolley recently received a grant from the Racine Community Foundation to continue to expand our Community Cancer Health Education efforts. This work will be conducted in partnership with the Racine Kenosha Community Action Agency. Dr. Stolley is also funded through three awards from the National Cancer Institute and grants from the American Cancer Society and the Greater Milwaukee Foundation.
Disparities, Survivorship, Outcomes, and Community Engaged Researchers:
Kirsten Beyer, PhD
My research utilizes geographic information systems (GIS), epidemiological and qualitative approaches to examine the spatial patterning of cancer burdens and the complex processes that cause the patterns.
Matthew Dellinger, PhD
I am a co-investigator at the Great Lakes Native American Research Center for Health (GLNARCH). Health research in Indian Country faces diverse challenges. I serve the tribal community in many ways, including scientific research, quantitative analysis, cinematography/editing, digital imaging, and risk assessment. Specifically, I focus on improving access to toxicological and risk assessment data in the relevant community via culturally-tailored media.
Jeffrey Engelmann, PhD
I use functional brain imaging techniques to better understand the neurobiological basis of nicotine dependence, as well as other behaviors that increase an individual's risk for cancer. Dr. Engelmann recently received a highly competitive grant from the Greater Milwaukee Foundation to study menthol cigarette use in African Americans in Milwaukee, and the impact of menthol on nicotine addition and quitting smoking.
Kathryn Flynn, PhD
My research focuses on the development and analysis of patient-reported outcome measures, primarily with the NIH PROMIS initiative to standardize measurement of patient-reported outcomes across chronic disease populations. I also conduct research on patient decision making, most recently with patients seeking care for infertility.
Mary Horowitz, MD, MS
I lead a large multicenter outcomes research group focused on factors influencing the use and success of hematopoietic stem cell transplantation (HCT). I am also principal investigator of the Data and Coordinating Center of the Blood and Marrow Transplant Clinical Trials Network, an NIH-funded trial group conducting multicenter Phase II and III trials addressing HCT-related issues.
Sailaja Kamaraju, MD
I am interested in breast cancer clinical care, research, outcomes research and am passionate about survivorship. Dr. Kamaraju is the chair and leader of the annual MCW Cancer Disparities Symposium.
Ann Nattinger, MD, MPH
Dr. Nattinger conducts research in the area of cancer related health services research. Her studies include the relationship of cancer treatments to outcomes, survivorship care, and disparities in cancer therapy and outcomes.
Joan Neuner, MD
My cancer-related research is focused on outcomes and quality of care. I am also interested in patient communication, particularly related to treatment risks and benefits, and also patient communication and quality of care in cancer. My primary focus has been breast cancer and its bony complications, but I have also published work regarding prostate cancer patterns of care and colon cancer screening. I am co-leader of the P.S. program.
Lilliana Pezzin, PhD
Breast cancer processes of care and outcomes; effectiveness and cost effectiveness of alternative breast cancer therapies; burden of disease; methodological issues related to heterogeneity of treatment effects and treatment choices; access to care and disparities therein.
J. Doug Rizzo, MD
Primary research related interests are late effects of hematopoietic cell transplantation (HCT), access to hematopoietic cell transplantation, center specific outcomes for HCT and health IT issues.
Wael Saber, MD
My research focuses on comparative effectiveness analyses of large databases to identify predictors of favorable post hematopoietic cell transplantation outcomes. I specially focus on the role of hematopoietic cell transplantation for myeloid malignancies and myeloproliferative neoplasms.
Tina Yen, MD
I am a surgical oncologist with a special interest in breast cancer and health services research. My research focuses on studying breast cancer quality of care, patterns of care, and the relationship of these patterns of care to outcomes of care through the analysis of large administrative data sets and tumor registry data.